Skip to content

A Retrospective Cohort Study of HFRS

A Retrospective Cohort Study of Hemorrhagic Fever With Renal Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06020326
Enrollment
500
Registered
2023-08-31
Start date
2022-05-05
Completion date
2023-12-31
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HFRS

Brief summary

The goal of this retrospective cohort study is to learn about the clinial characteristics of HFRS patients, explore the risk factors of the occurrence and death of HFRS, and build a risk prediction model for HFRS.

Detailed description

HFRS remains an important public health issue in China, which not only poses a threat to people's physical health and safety, but also has a serious impact on social and economic development. At present, there is no unified standard for clinical prediction of the occurrence and death of HFRS. In order to better prevent and treat HFRS, this multicenter retrospective clinical study is designed to include HFRS inpatients, and collect their demographics, epidemiological history, hospitalization information, clinical manifestation, laboratory results, imaging results, treatment plan and outcome.

Interventions

None listed

Sponsors

Tongji Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

The patients must meet all of the following criteria: * Inpatient with clinical diagnosis of Haemorrhagic Fever with Renal Syndrome

Exclusion criteria

Exclude patients who meet any of the following criteria: * Patients with previous chronic kidney disease * Pregnant or perinatal patients * Patients unsuitable for inclusion by investigators' evaluation

Design outcomes

Primary

MeasureTime frameDescription
short-term mortality90 days post diagnosed HFRS28-day and 90-day mortality after diagnosed as HFRS

Countries

China

Contacts

Primary ContactQin Ning, Professor
qning@vip.sina.com+8613971521450

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026